Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Groll

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Angewandte Chemie (International Ed. in English)|May 26, 2017
Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In VivoKarthikeyan Annamalai, Falk Liberta, Marie-Theres Vielberg, et al.
Angewandte Chemie (International Ed. in English)|November 14, 2015
Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX AssociationAxel Pahl, Markus Lakemeyer, Marie-Theres Vielberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2014
The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulinsMatthias J Feige, Melissa A Gräwert, Moritz Marcinowski, et al.
ACS Chemical Biology|December 1, 2017
Identification and Experimental Characterization of an Extremophilic Brine Pool Alcohol Dehydrogenase from Single Amplified GenomesStefan W Grötzinger, Ram Karan, Eva Strillinger, et al.
Journal of Medicinal Chemistry|July 21, 2016
Structure-Based Design of β5c Selective Inhibitors of Human Constitutive ProteasomesBo-Tao Xin, Gerjan de Bruin, Eva M Huber, et al.
Angewandte Chemie (International Ed. in English)|November 29, 2023
Structure of Staphylococcus aureus ClpP Bound to the Covalent Active-Site Inhibitor Cystargolide AAstrid Illigmann, Marie-Theres Vielberg, Markus Lakemeyer, et al.
Chemmedchem|May 19, 2010
Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparumJulie G Geist, Susan Lauw, Victoria Illarionova, et al.
Journal of Medicinal Chemistry|October 23, 2008
Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamidesRama Rao Manam, Katherine A McArthur, Ta-Hsiang Chao, et al.
Science (New York, N.Y.)|March 21, 2024
Evolution-inspired engineering of nonribosomal peptide synthetasesKenan A J Bozhüyük, Leonard Präve, Carsten Kegler, et al.
Journal of Medicinal Chemistry|July 10, 2014
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomesGerjan de Bruin, Eva M Huber, Bo-Tao Xin, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Angewandte Chemie (International Ed. in English)|May 26, 2017
Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In VivoKarthikeyan Annamalai, Falk Liberta, Marie-Theres Vielberg, et al.
Angewandte Chemie (International Ed. in English)|November 14, 2015
Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX AssociationAxel Pahl, Markus Lakemeyer, Marie-Theres Vielberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2014
The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulinsMatthias J Feige, Melissa A Gräwert, Moritz Marcinowski, et al.
ACS Chemical Biology|December 1, 2017
Identification and Experimental Characterization of an Extremophilic Brine Pool Alcohol Dehydrogenase from Single Amplified GenomesStefan W Grötzinger, Ram Karan, Eva Strillinger, et al.
Journal of Medicinal Chemistry|July 21, 2016
Structure-Based Design of β5c Selective Inhibitors of Human Constitutive ProteasomesBo-Tao Xin, Gerjan de Bruin, Eva M Huber, et al.
Angewandte Chemie (International Ed. in English)|November 29, 2023
Structure of Staphylococcus aureus ClpP Bound to the Covalent Active-Site Inhibitor Cystargolide AAstrid Illigmann, Marie-Theres Vielberg, Markus Lakemeyer, et al.
Chemmedchem|May 19, 2010
Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparumJulie G Geist, Susan Lauw, Victoria Illarionova, et al.
Journal of Medicinal Chemistry|October 23, 2008
Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamidesRama Rao Manam, Katherine A McArthur, Ta-Hsiang Chao, et al.
Science (New York, N.Y.)|March 21, 2024
Evolution-inspired engineering of nonribosomal peptide synthetasesKenan A J Bozhüyük, Leonard Präve, Carsten Kegler, et al.
Journal of Medicinal Chemistry|July 10, 2014
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomesGerjan de Bruin, Eva M Huber, Bo-Tao Xin, et al.
Pageof 21